• what's New?

 MDADD (Molecular Dynamics for Antibody Drug Development) is a new project for antibody-based drug design started with a group of leading researchers from multidisciplinary fields under the direction of Dr. Tatsuhiko Kodama at the Research Center for Advanced Science and Technology, the University of Tokyo.

The goal of this project is to develop multifunctional antibodies that can be used for targeted treatments in advanced cancer.

Our aim is to engineer antibody drugs for advanced cancer that specifically recognize cancer cells. These antibodies will be useful for precise diagnosis of cancer. They can also be applied for the treatment of cancer with minimal side effects.